ライフサイエンスコーパス: seropositivity

1 n in Brazil, both tests detected 28%(n = 17) seropositivity.

2 alarials were associated with HCV subtype 4k seropositivity.

3 nd individual characteristics that relate to seropositivity.

4 ated with increasing age and cytomegalovirus seropositivity.

5 ere associated with 16/18 and 31/33/45/52/58 seropositivity.

6 and B-cell proportions by BK, JC, and HPyV9 seropositivity.

7 ause survival in relation to HPV16 E6 and E7 seropositivity.

8 = 1.7 x 10(-8)), to be associated with HPV77 seropositivity.

9 utaneous vaccine with respect to the rate of seropositivity.

10 rology, likely due to the high prevalence of seropositivity.

11 e also evaluated factors associated with HEV seropositivity.

12 s, only older age remained predictive of HEV seropositivity.

13 ost significant risk factors associated with seropositivity.

14 s for a rapid, noninvasive test for COVID-19 seropositivity.

15 continues to challenge the interpretation of seropositivity.

16 xposure is independently associated with HPV seropositivity.

17 for human papillomavirus (HPV)-16 and HPV-18 seropositivity.

18 nce of H1N1pdm09 vaccination or pre-pandemic seropositivity.

19 were strongly associated with post-pandemic seropositivity.

20 fer significantly according to recipient CMV seropositivity.

21 recent seroconversion, as well as sustained seropositivity.

22 r 1 week in April 2020, and risk factors for seropositivity.

23 t travel (aOR:1.3, [1.1-1.8]) were linked to seropositivity.

24 ause survival in relation to HPV16 E6 and E7 seropositivity.

25 HBV genotype C infection and maternal HBsAg seropositivity.

26 magnetic resonance imaging, correlated with seropositivity.

27 nsity quintile experienced increased odds of seropositivity (10.3 [8.7-12.2]) compared with residents

28 usion criteria were as follows: (1) AQP4-IgG seropositivity, (2) myelitis attack and (3) MRI spinal c

29 The highest seropositivity (25/155) was observed within the age grou

30 %-70%] vs 98% [95% CI, 95%-100%]), and mumps seropositivity (59% [95% CI, 55%-64%] vs 97% [95% CI, 94

31 assay (ELISA) thresholds for HPV16 and HPV18 seropositivity (8 and 7 ELISA units/mL, respectively, fo

32 Age <18 years, recipient cytomegalovirus seropositivity, absolute lymphocyte count <300 cells/uL

33 CMV seropositivity accentuates further the accumulation of h

34 2.36) and inversely associated with SE36IgG1 seropositivity (adjusted OR: 0.37; 95% CI 0.21-0.64) and

35 BL was positively associated with HRP-IIIgG3 seropositivity (adjusted OR: 1.60; 95% CI 1.08-2.36) and

36 Adv36 seropositivity (Adv36 + ) was assessed using ELISA.

37 Seropositivity after 1 vaccine dose among children with

38 , which was not significantly different from seropositivity after a two-dose MCV schedule starting la

39 atitis A virus (anti-HAV) on the duration of seropositivity after hepatitis A vaccination during infa

40 Seropositivity against at least 3 anogenital HPV types i

41 er, APECED subjects selectively demonstrated seropositivity against BPI fold containing family A memb

42 ese data suggest that in FEP, NMDAR antibody seropositivity alone is not an indication for using immu

43 Although the frequency of seropositivity among all participants through age 10 yea

44 Independent predictors of seropositivity among children with PHIV were receipt of

45 piratory syndrome coronavirus 2 (SARS-CoV-2) seropositivity among health care workers at a New York C

46 ound statistically significant reductions in seropositivity among HIV-infected children compared with

47 B. pseudomallei from a soil sample and high seropositivity among patient contacts suggest at least r

48 Seropositivity among recipients of 2 vaccine doses was >

49 Seropositivity amongst unvaccinated animals born after t

50 a significantly higher risk of toxocariasis seropositivity and Anisakis simplex sensitization when c

51 prevalence of Toxocara spp. and Ascaris spp. seropositivity and associations with allergic diseases a

52 observed associations between genus-beta HPV seropositivity and BCC.

53 no association was observed between beta-HPV seropositivity and beta-HPV DNA-negative BCC.

54 to examine the associations between pathogen seropositivity and cognitive impairment.

55 und no significant association between Adv36 seropositivity and different BMI categories, or glucose

56 t there was no relationship between antibody seropositivity and either ON relapse rate or visual acui

57 ion that showed association between anti-HEV seropositivity and functional epsilon3 and epsilon4 alle

58 (RVV) seroconversion (primary outcome), and seropositivity and geometric mean titer (GMT) (secondary

59 Seropositivity and higher IgG antibody levels against CM

60 Prevalence of paternal seropositivity and incidence of recent infection were ca

61 s study investigated the prevalence of Adv36 seropositivity and its association with obesity and diab

62 ates the association between cytomegalovirus seropositivity and outcome in a large population of noni

63 retation of epidemiological data in terms of seropositivity and protection of PV infections in genera

64 Epidemiological surveys for MCPyV seropositivity and sequencing analyses of healthy human

65 was no significant association between HSV-2 seropositivity and the presence of fibroids (multivariab

66 ical information on the relationship between seropositivity and toxocariasis is limited.

67 No concordance between seropositivity and tumor DNA status was observed for HPV

68 ion less than 3 vertebral segments, AQP4-IgG seropositivity, and a final diagnosis of NMO or NMOSD.

69 nfection with a detectable viral load, HBeAg seropositivity, and absence of HIV infection.

70 tuberculosis infection, hepatitis B and HIV seropositivity, and child and adult vaccination needs th

71 90 and were followed for analysis of safety, seropositivity, and neutralizing antibodies to DENV-1-4.

72 ptic neuritis, transverse myelitis, AQP4-IgG seropositivity, and recurrent myalgias with hyperCKemia.

73 hyroid peroxidase, and anti-transglutaminase seropositivity, and these autoantibodies did not correla

74 tenatal care coverage, and syphilis testing, seropositivity, and treatment in antenatal care.

75 Seropositivity (anti-HAV >/=20 mIU/mL) 30 years after th

76 ransplant recipients that betapapillomavirus seropositivity around transplantation significantly incr

77 stics, behavior, and hepatitis C virus (HCV) seropositivity assessed the relationship of mtDNA CN to

78 Titers remained above the threshold for seropositivity at 1 year after vaccination in nearly all

79 es to assess risk factors for human MERS-CoV seropositivity at a farm complex in Qatar.

80 g for monitoring of SARS-CoV-2 infection and seropositivity at a population scale.

81 Determinants of seropositivity at age 4 were cord seropositivity (JCPyV,

82 robust variance to identify determinants of seropositivity at age 4.

83 iable DRB locus within the MHC region to HPV seropositivity at both the individual HPV type level and

84 ng seronegative HIV-infected adults, measles seropositivity at end of follow-up ranged from 0% to 56%

85 Positive sfEMG and AchR Ab seropositivity at the time of diagnosis increased the ri

86 sed by occupational flour exposure and wheat seropositivity based on cross-reactivity to grass pollen

87 f 225 children was evaluated for CMV and EBV seropositivity before 2 years of age and for vaccination

88 Measuring seropositivity before vaccine introduction provides base

89 screening study of various NAbs showed 22.5% seropositivity belonging mostly to VGKC-complex antibodi

90 n assay and rubella seroprotection and mumps seropositivity by enzyme immunoassay.

91 characteristic MOGAD phenotype, (2) MOG-IgG seropositivity by live cell-based assay and (3) MRI lesi

92 h neurobehavioral disease is associated with seropositivity, causality is unproven.

93 nfirmed human infections but higher rates of seropositivity compared to A(H5) or A(H7) subtype viruse

94 Persistence of seropositivity conferred by hepatitis A vaccine administ

95 nses measured using an unenhanced PRNT (GSK; seropositivity cutoff and threshold, 2.5 and 4 times the

96 ed significant IgG boosting and waning above seropositivity cutoffs, underscoring the value of longit

97 Seropositivity, defined by K8.1/LANA or in combination w

98 Seropositivity distinguishes autoimmune glial fibrillary

99 Recipient hepatitis C virus seropositivity, donor age, donor cause of death, and lif

100 Type-specific persistent seropositivity entailed elevated point estimates for SCC

101 Helicobacter pylori seropositivity, especially H. pylori cagA positivity, wa

102 Had we visited only 20 communities, seropositivity estimates would have ranged from 13% to 3

103 were significantly associated with TES-ELISA seropositivity except vitreits (X(2) = 8.557, p = 0.003)

104 esearch could explore whether differences in seropositivity following infection result in differentia

105 The primary end points were seropositivity for antibodies against measles and advers

106 nfluenza A(H7N9) infection in China found no seropositivity for antibodies specific for avian-origin

107 c groups, the number (weighted frequency) of seropositivity for antibody to HAV was 958 (24.9%), 802

108 In summary, seropositivity for certain HPV types was associated with

109 We aimed to examine whether seropositivity for CMV and the level of CMV immunoglobul

110 Seropositivity for CMV or EBV infection alters B cell re

111 T-cell subsets and immunoglobulin G seropositivity for CMV, EBV, herpes-simplex virus 1, and

112 nital HPV infections, abnormal cytology, and seropositivity for cutaneous HPVs.

113 for at least 1 of the 6 HY-Abs, and 3-month seropositivity for each HY-Ab was associated with a pers

114 Seropositivity for hepatitis C virus (HCV) predicts lowe

115 The prevalence ratio of seropositivity for HIV-positive females versus HIV-negat

116 Seropositivity for HPV types in genera alpha or beta inc

117 l associations were observed between BCC and seropositivity for HPV types in genus-alpha (odds ratio

118 nt anal HPV infections, HPV viral loads, and seropositivity for HPV were predictors of anal HSIL, eit

119 nt donor to the recipient, despite recipient seropositivity for JCPyV at the time of transplantation.

120 Infant HBsAg seropositivity for more than 6 months was defined as chr

121 Seropositivity for pgp3 antibody varied from 1.4% (95% C

122 Seropositivity for SARS-CoV-2 was 3 times more likely in

123 PTB) individuals with (Ss+) or without (Ss-) seropositivity for Strongyloides stercoralis infection.

124 ubset of patients studied for all endpoints, seropositivity for the E6 and E7 proteins was significan

125 Seropositivity for tTGA resolved spontaneously, without

126 roup, antirotavirus immunoglobulin A and IgG seropositivity frequencies before vaccination (52.7% and

127 Two doses of the vaccine yielded seropositivity frequencies of 92.3%, 95.9%, and 99.0% (w

128 ore, patients with p16 staining and E6 or E7 seropositivity had favorable survival from oropharyngeal

129 EBV seropositivity has been connected to immunomodulatory ef

130 ding TL outliers, and when adjusting for CMV-seropositivity, HCV-seropositivity, time spent with dete

131 mortality included recipient cytomegalovirus seropositivity (HR 1.40, 95% CI 1.13-1.74, p=0.0020), re

132 2R-AB in longitudinal serum samples revealed seropositivity in 44% (59 out of 134) of primary MN case

133 ch, 2020, were associated with lower odds of seropositivity in July, 2020 (0.4 [0.3-0.5]) when compar

134 single-nucleotide polymorphisms and anti-HEV seropositivity in non-Hispanic blacks or between any sin

135 single-nucleotide polymorphisms and anti-HEV seropositivity in non-Hispanic whites or Mexican America

136 This high rate of Toxocara seropositivity in ocular patients should alert ophthalmo

137 CMV seropositivity in other conditions is associated with ar

138 ce of immunoblot-confirmed B burgdorferi IgG seropositivity in our uveitis patients is only slightly

139 yme Total assay exhibits an improved rate of seropositivity in patients with early Lyme infection.

140 over years, and prolonged waxing and waning seropositivity in some subjects, raises the possibility

141 ncaster, we confirm previous observations of seropositivity in the majority of the population.

142 Risk factors for HTLV-1 seropositivity included intravenous injections at hospit

143 strata, and analyzed factors associated with seropositivity, including age, gravidity, human immunode

144 f our original cohort revealed that AQP4-IgG seropositivity increased from 56% to 75% for NMO, 5% to

145 Seropositivity increased slightly with age in only one d

146 In adjusted analyses, HIV seropositivity increased the hazard of death by 24% ( P

147 respectively), whereas donor cytomegalovirus seropositivity increased the risk for late-onset IA (ie,

148 Seropositivity increased with increasing days of illness

149 antibody to HEV (anti-HEV) immunoglobulin G seropositivity indicating past or recent HEV infection a

150 The seropositivity induced by hepatitis A vaccine given to c

151 wave rose to 23%, either due to prepandemic seropositivity, infection or vaccination.

152 omarker of Epstein-Barr virus (anti-EBNA IgG seropositivity), infectious mononucleosis, and smoking s

153 immunodeficiency virus (HIV) and hepatitis B seropositivity, intestinal parasite test positivity, nee

154 JC virus (JCV) seropositivity is a risk factor for progressive multifoc

155 In the postvaccination era, anti-HBc seropositivity is a useful marker for OBI screening in H

156 spite adequate antiretroviral treatment, HIV seropositivity is associated with decreased survival in

157 eroprevalence rate of 36%, we find that HCMV seropositivity is associated with lower NK cell IFN-gamm

158 Seropositivity is associated with neurologic diseases an

159 Our findings suggest that PyV seropositivity is common in the United States and varies

160 ssociation noted between rs41270488 and HPV8 seropositivity is driven by two independent variants, na

161 High seropositivity is found in horses worldwide with approxi

162 tributable fraction of FGC for prevalent HCV seropositivity is high in women (79.8%).

163 HPV16 E6 seropositivity is relatively common before diagnosis of

164 We conclude that donor and/or recipient CMV seropositivity is still associated with an adverse progn

165 minants of seropositivity at age 4 were cord seropositivity (JCPyV, HPyV7, HPyV10, CMV), vaginal deli

166 Conflicting evidence indicates that HIV seropositivity may influence the outcome of patients wit

167 galovirus (CMV)-specific cells, although CMV seropositivity modulated the distribution of lymphocyte

168 e agents (n = 8), and reported anti-JC virus seropositivity (n = 13).

169 all schedules, except HPV18, with the lowest seropositivity observed among 3D women (60.0%; 95% CI, 4

170 icient 0.54; p<0.0001) and increased odds of seropositivity (odds ratio 1.59 [95% CI 1.1-2.3]) adjust

171 ic neighbourhoods experienced higher odds of seropositivity (odds ratio 3.9 [95% CI 3.4-4.6] and 2.3

172 ntly associated with a CD4/CD8 ratio <1: CMV seropositivity (odds ratio [OR], 1.9 [95% confidence int

173 s, 19.5% (22 of 113) for blood samples, with seropositivity of 62.8% (71 of 113 samples) and with inc

174 inked immunosorbent assay (ELISA), we obtain seropositivity of 77%.

175 .6% (11/114) by crude antigen ELISA (overall seropositivity of 9.4% [14/149]).

176 s with chronic urticaria more frequently had seropositivity of fasciolosis, Anisakis simplex sensitiz

177 ignificantly associated with distribution of seropositivity of HCV in the studied population (p < 0.0

178 ow specificity in areas where the background seropositivity of healthy people is high.

179 The negative prognostic effects of CMV seropositivity of the donor and/or the recipient (vs CMV

180 from a CMV-seronegative donor, cases of CMV seropositivity of the donor and/or the recipient showed

181 We estimated the effect of HIV seropositivity on patients' OS while accounting for comm

182 on analyses assessed the effects of antibody seropositivity on the parasite clearance half-life (PC1/

183 aplotype was negatively associated with ANO2 seropositivity (OR = 0.6; 95%CI: 0.5 to 0.7).

184 eroprevalence, with significant variation in seropositivity over time and among roosts.

185 We found no associations between H. pylori seropositivity overall either by whole-cell ELISA test o

186 , comorbidity index >=3, and cytomegalovirus seropositivity (P < .001 for all variables).

187 ic CD8(+) T-cell analysis (P = .05), and CMV seropositivity (P = .01) were associated with a higher p

188 FoxP3 PTLDs were associated with hepatitis C seropositivity (P = 0.03).

189 flammatory markers, disease activity scores, seropositivity, physical disability, destructive changes

190 95% confidence interval, 1.30-23.62), as did seropositivity (positive likelihood ratio, 3.69 [1.67-8.

191 Seropositivity predictors were identified using multivar

192 CMV seropositivity (prevalence 59%) was associated with incr

193 was assigned to estimate the probability of seropositivity prior to antibody test results.

194 By using known anti-HBc seropositivity rate in children in our serosurveys, the

195 4-IgG positive, yielding an overall AQP4-IgG seropositivity rate of 89%.

196 nfection in fathers, relative to the average seropositivity rate of 9.8% for boys and men aged 12-49

197 sts were conducted in 905 individuals with a seropositivity rate of 9.9% (90/905); 61 seropositives w

198 BK polyomavirus is ubiquitous, with a seropositivity rate of over 75% in the adult population.

199 d 46 (26-82) against DENV 4; and tetravalent seropositivity rate was 89% (79-96), 86% (80-92), 97% (9

200 The observed perinatal HCV seropositivity rate was compared to the expected rate (5

201 Seropositivity rates and corresponding geometric mean ti

202 offs selected using a specificity of 95% and seropositivity rates compared between horses affected wi

203 nsplant patients with influenza A (n = 116), seropositivity rates for strain-specific antibodies were

204 Expected infant seropositivity rates reached 80% vs 55% following second

205 Although seropositivity rates remained similarly high (48 [94%] o

206 Seropositivity rates varied significantly for DENV-4 acc

207 At Month 36, seropositivity rates were 97.3%, 98.7%, 88.0% and 56.0%

208 cLIA seropositivity rates were above 95% for all HPV vaccine

209 Geometric mean titers (GMTs) and seropositivity rates were compared between the different

210 imary endpoint were GMCs and expected infant seropositivity rates, defined by birth anti-PT >30 enzym

211 Recurrent hyperCKemia accompanying AQP4-IgG seropositivity reflects targeting of skeletal muscle AQP

212 Neighborhood seropositivity results guided soil sampling to isolate B

213 efined by infant hepatitis B surface antigen seropositivity (risk ratio = 0.3, 95% confidence interva

214 nfidence interval 0.2-0.4) or infant HBV DNA seropositivity (risk ratio = 0.3, 95% confidence interva

215 netheless, the model indicated that anti-HAV seropositivity should persist for >/=30 years after vacc

216 HPV16 E6 seropositivity tended to increase in blood samples drawn

217 resulted in outer surface protein A-specific seropositivity that led to reductions of 23% and 76% in

218 Our results underline the importance of seropositivity threshold determination and reader traini

219 childhood available for sampling maintained seropositivity through age 15-16 years; however, seropos

220 d when adjusting for CMV-seropositivity, HCV-seropositivity, time spent with detectable HIV viremia,

221 g/fall waves of the pandemic for evidence of seropositivity (titer >/=40) using the hemagglutination

222 We used a multiplex panel to assess whether seropositivity to 15 Helicobacter pylori proteins was as

223 herefore investigated whether preexisting Ad seropositivity to 7 different Ad serotypes was associate

224 The age-adjusted prevalence of seropositivity to A(H1N1)pdm09 by year-end 2009 was 36.9

225 owever, 69%-74% of children maintained their seropositivity to AMA1 alleles and 42%-52% to MSP2 allel

226 Seropositivity to avian influenza (AI) via low-level ant

227 associations with gastric adenocarcinoma and seropositivity to different Helicobacter pylori antigens

228 These were IgG seropositivity to Epstein-Barr virus nuclear antigen (EB

229 The association of seropositivity to H pylori proteins, as well as protein-

230 Seropositivity to H. pylori proteins was associated with

231 Seropositivity to H. pylori was assessed using both mult

232 stitution (N145K/R) was sufficient to affect seropositivity to H3N2v viruses in some individuals.

233 of HIV-infected patients exhibit persistent seropositivity to HIV-1 and evidence of immune activatio

234 Seropositivity to JC, MCV, and HPyV7 increased with age.

235 Seropositivity to more herpesviruses was additively asso

236 the Step study, we observed that preexisting seropositivity to multiple Ad serotypes was not intrinsi

237 nital HPV infections, abnormal cytology, and seropositivity to nongenital HPVs.

238 Seropositivity to PVs was associated with increasing age

239 onclusions, our cross-sectional study showed seropositivity to the NT5c1A antibody is associated with

240 ip between total infectious burden (additive seropositivity to various microbes) and cognition/AD.

241 immunosorbent assay units (EU)/mL to confer seropositivity until 3 months of age.

242 owed by additional MCV doses results in high seropositivity, vaccine effectiveness, and T-cell respon

243 After 2 TDV doses, seropositivity was >95% in all 5 groups for DENV-1-3 and

244 count was 62 (range, 0-526) cells/muL; KSHV seropositivity was 30.7% (95% confidence interval [CI],

245 e determined that the appropriate measure of seropositivity was a positive result with both pan-Ig as

246 CMV seropositivity was also associated with impaired learnin

247 In particular, CMV seropositivity was an independent risk factor for cardio

248 Seropositivity was associated with a reduced cervical bu

249 However, HSV-2 seropositivity was associated with a shorter time to the

250 H pylori VacA-specific seropositivity was associated with an 11% increased odds

251 CMV seropositivity was associated with an increased risk of

252 HTLV-1 seropositivity was associated with female sex, older age

253 HTLV-2 seropositivity was associated with female sex, older age

254 However, CMV seropositivity was associated with higher levels of prev

255 Among older adults, HSV-1 seropositivity was associated with immediate memory impa

256 Seropositivity was associated with improved patient surv

257 Parental Toxocara spp. seropositivity was associated with increased offspring a

258 fspring than parents; however, Toxocara spp. seropositivity was associated with increased risk of all

259 Among children, HSV-1 seropositivity was associated with lower reading and spa

260 For HPV-18, although seropositivity was associated with lower risk of ASCUS+

261 seropositive but MCV-seronegative, and HPyV7 seropositivity was associated with prolonged glucocortic

262 Toxocara spp. seropositivity was associated with wheeze (2.97[1.45- 7.

263 and crypt depth measurements showed that HEV seropositivity was associated with worse enteropathy (P

264 e screened by recombinant ELISA and MERS-CoV seropositivity was confirmed by recombinant immunofluore

265 Seropositivity was defined as an hSBA titer of 4 or high

266 Helicobacter pylori seropositivity was defined as those positive to >/= 4 an

267 expected, a high percentage of autoantibody seropositivity was detected against Ro52, Ro60, and La i

268 C. trachomatis seropositivity was detected in 90% of the infected group

269 A Bayesian hierarchical model for P knowlesi seropositivity was developed, incorporating questionnair

270 oped hepatobiliary cancer, the prevalence of seropositivity was higher: 100% for gallbladder cancer,

271 In multivariable analyses, HIV seropositivity was independently associated with mortali

272 HPV16 E6 seropositivity was less common for cancers of the cervix

273 positivity through age 15-16 years; however, seropositivity was less frequent among those starting va

274 Seropositivity was lower among males than among females

275 Seropositivity was maintained at month 12.

276 HPV16 E6 seropositivity was present in 29.2% of individuals (seve

277 HPV16 E6 seropositivity was present in prediagnostic samples for

278 HPV16 E6 seropositivity was present more than 10 years before dia

279 on Into Cancer and Nutrition study, HPV16 E6 seropositivity was present more than 10 years before oro

280 Seropositivity was significantly higher in IBH horses co

281 Seropositivity was significantly lower in participants c

282 In multivariable analyses, HPV-16 seropositivity was significantly more common in WSM vs M

283 Seropositivity was very strongly associated with improve

284 Among asymptomatic contacts, seropositivity was weakly correlated with exposure level

285 nfection with herpesviruses, measured by IgG seropositivity, was generally not associated with dement

286 IgG3, C1q fixation, and opsonic-phagocytosis seropositivity were associated with a faster PC1/2 (rang

287 rus (CMV) and herpes simplex virus 1 (HSV-1) seropositivity were associated with cognitive impairment

288 Among middle-aged adults, HSV-1 and CMV seropositivity were associated with impaired coding spee

289 Factors significantly associated with seropositivity were having skin wounds, sores, or ulcers

290 rted between 12 and 24 weeks of age, odds of seropositivity were increased 13.7 times (95% CI 3.1-60.

291 ariate analyses, factors associated with HEV seropositivity were increasing age (P-trend<0.001), birt

292 Independent risk factors for HCV subtype 4r seropositivity were intramuscular tuberculosis therapy,

293 JC and TSV seropositivity were more common among men than among wom

294 Neither antibody levels nor the rate of seropositivity were significantly reduced by heat inacti

295 In addition, the associations with seropositivity were similar across smoking and/or drinki

296 edictors of rubella seroprotection and mumps seropositivity were similar.

297 We also assessed odds of seropositivity with respect to age of ART initiation and

298 nical infections in patients with or without seropositivity, with an annual incidence of 7.7%.

299 a susceptibility locus (rs41270488) for HPV8 seropositivity within the major histocompatibility compl

300 We hypothesized, therefore, that HCMV seropositivity would be associated with altered NK cell